Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Ohki Healthcare Holdings Co., Ltd. (3417:JPX), powered by AI.
Ohki Healthcare Holdings Co., Ltd. is currently trading at ¥1,103. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Ohki Healthcare Holdings Co., Ltd. on Alpha Lenz.
Ohki Healthcare Holdings Co., Ltd.'s P/E ratio is 5.7.
“Ohki Healthcare Holdings Co., Ltd. trades at a P/E of 5.7 (undervalued) with solid ROE of 9.0%.”
Ask for details →Ohki Healthcare Holdings Co., Ltd. is a prominent healthcare services provider based in Japan, playing a crucial role in the Japanese healthcare system. The company's primary function is to facilitate the distribution and supply of pharmaceuticals, medical devices, and healthcare-related products. Ohki Healthcare Holdings is a key player in ensuring efficient delivery and availability of these vital products to hospitals, clinics, and pharmacies across the region, thereby supporting public health infrastructure. Notably, the company operates within the healthcare and pharmaceutical sectors, which are critical to maintaining public health and addressing medical needs. Its involvement in these essential industries underscores its importance in the supply chain of healthcare products. By offering comprehensive services that span logistics, inventory management, and product distribution, Ohki Healthcare Holdings Co., Ltd. contributes to the seamless operation of healthcare services, highlighting its vital role in the financial market centered around health and medical care.
“Ohki Healthcare Holdings Co., Ltd. trades at a P/E of 5.7 (undervalued) with solid ROE of 9.0%.”
Ask for details →Ohki Healthcare Holdings Co., Ltd. (ticker: 3417) is a company listed on JPX in the Healthcare sector (Pharmaceutical Retailers). It has approximately 648 employees. Market cap is $15.0B.
The current price is 1,103 with a P/E ratio of 5.7x and P/B of 0.49x.
ROE is 8.97% and operating margin is 0.79%. Annual revenue is $349.5B.